The rate of suspected adverse reactions linked to mRNA jabs is 0.13%: HSA, Latest news from Singapore
The rate of suspected adverse events related to Covid-19 vaccines as part of the national vaccination program is 0.13%, the Health Sciences Authority (HSA) said yesterday.
The rate of serious adverse events, such as anaphylaxis, is much lower at 0.006%.
For the national program, 8,716,085 doses of Pfizer-BioNTech and Moderna mRNA vaccines had been administered as of August 31, with 11,737 suspected adverse reactions reported.
Of these, 498 reports were classified as serious adverse events.
The report – the fifth national regimen vaccine safety update – included a second update on the Sinovac-CoronaVac jabs under the special pathway.
As of August 31, 90 reports of suspected adverse reactions to Sinovac-CoronaVac vaccine have been reported, including five serious.
With 168,439 doses administered over the same period, this represents a rate of 0.053% for suspected cases and 0.003% for severe cases.
These serious events were: one report of Bell’s palsy, one severe allergic reaction and dizziness with ringing in the ears, and two reports of anaphylaxis.
The HSA said: “The type and number of reports received for the different Covid-19 vaccines are not directly comparable as the vaccines may have been used in the immunization program for different durations and may have been given to different numbers of people. people. , with different underlying medical conditions and in different settings. “
For Pfizer and Moderna vaccines, the most commonly reported symptoms were those typically seen after vaccination, such as dizziness, shortness of breath, injection site pain, and allergic reactions, and usually resolve within a few days.
Among severe cases, the most frequently reported cases were anaphylaxis and other serious allergic reactions.
Data to date shows that the benefits of the Pfizer-BioNTech and Moderna Covid-19 vaccines continue to outweigh the known risks in a pandemic, the HSA said. – THE TIMES OF THE STRAITS